Oct 29, 2015, 13:00 PM by Michael Croft

Bio-IT World | At Direct Genomics in Shenzhen, He Jiankui is bringing back the sequencing technology of the defunct Helicos Biosciences to build a new DNA sequencer for the clinic, promising targeted diagnostic tests with minimal sample preparation and low input requirements.

Oct 28, 2015, 16:25 PM by Michael Croft

Bio-IT World | The BGISEQ-500, using a dramatically reengineered version of Complete Genomics' "DNA nanoball" sequencing, is designed to compete with Illumina's NextSeq instruments on both price and throughput — at least in the Chinese markets where it is being made available next year.

Oct 28, 2015, 13:05 PM by Michael Croft

HPCwire | Accelerating genomics analysis remains one of the toughest challenges in life science research. All manner of optimizations are in use - disk streaming, op

Oct 26, 2015, 17:30 PM by Michael Croft

Bio-IT World News Brief | Today at the OpenStack Summit in Tokyo, SwiftStack released version 3.0 of its software with new features that extend the benefits of object storage to enterprise applications.

Oct 26, 2015, 16:10 PM by Michael Croft

Bio-IT World Bio-IT World is accepting entries to the 2016 Bio-IT World Best Practices competition. For the past thirteen years, the Bio-IT World Best Practices Awards have highlighted outstanding examples of innovations and partnerships serving as powerful forces for change in the life sciences.

Oct 26, 2015, 10:37 AM by Michael Croft

Xconomy | In the latest major partnership around gene editing therapies based on CRISPR-Cas9 technology, Vertex is investing $105 million upfront in CRISPR Therapeutics, to support programs in cystic fibrosis and sickle cell disease, among other conditions.

Oct 26, 2015, 05:05 AM by Michael Croft

HELSINKI, FINLAND - Oct 26, 2015 - BC Platforms, a world leader in genomic data management solutions, today announced that it has signed a partnership agreement with Helsinki University Hospital to use its genomic management platform to integrate, analyze and interpret their extensive clinical and genealogy data with next-generation sequencing data to provide innovative, personalized treatment options for breast cancer patients at the hospital

Oct 23, 2015, 14:40 PM by Michael Croft

Bio-IT World | Since being purchased by BGI, Complete Genomics has scrapped its sequencing-as-a-service business and shifted to manufacturing instruments. Although its first product, Revolocity, won't make any headway in the established research market, CEO Cliff Reid believes he's getting in on the ground floor of clinical sequencing, with a pitch for large healthcare organizations ready to take a chance on population genomics.

Oct 21, 2015, 09:23 AM by Michael Croft

MALVERN, PA - Oct 21, 2015 - CSM welcomed over 100 attendees to celebrate the opening of its second facility in the Great Valley Corporate Center of Malvern, Pennsylvania

Oct 21, 2015, 08:50 AM by Michael Croft

The New York Times | The genetic-testing company stopped providing health information in 2013 after the F.D.A. ordered it to prove the accuracy of results. Now it will provide carrier status for 36 diseases with FDA approval. The carrier status reports are part of the company's new "user experience", which includes more than 60 reports on health, ancestry, wellness, and personal traits and proprietary tools. Existing customers will be transitioned to the new experience as soon as possible, the company said.

Oct 20, 2015, 15:13 PM by Michael Croft

Washington Post | A public library in San Diego is home to what may be the world's first biotech laboratory-in-a-library.

Oct 20, 2015, 12:20 PM by Michael Croft

The Atlantic | New evidence from studies of genome folding and predictive models lends strong support to the hypothesis that the cell contains an "extrusion complex," a piece of molecular machinery that shapes genome architecture by forming DNA loops in predictable — and controllable — patterns.

Oct 20, 2015, 12:18 PM by Michael Croft

DURHAM, NC, UNITED STATES - Oct 20, 2015 - Cenduit, a joint venture between Quintiles and Thermo Fisher Scientific, is showcasing its solutions and expertise as the largest interactive response technology (IRT) specialist in the world by leading a panel at CBI’s 2015 Interactive Response Technologies in Clinical Trials Forum

Oct 20, 2015, 08:20 AM by Michael Croft

Bio-IT World | Several research groups have reported that the Hi-C technique, developed to study the 3D architecture of chromosomes, can be repurposed to assemble genomes de novo. Now, Dovetail Genomics has taken the next step with a service promising high-contiguity genomes with standard, short-read Illumina sequencers.

Oct 20, 2015, 08:19 AM by Michael Croft

PRINCETON, NJ - Oct 20, 2015 - Certara®, the global biosimulation technology-enabled drug development company, today announced that Japan’s new Agency for Medical Research and Development (AMED) has selected Certara’s Phoenix® WinNonlin® software for pharmacokinetic/pharmacodynamic (PK/PD) modeling and non-compartmental analysis of new drug candidates

Oct 19, 2015, 14:10 PM by Michael Croft

ST. LOUIS, MO, UNITED STATES - Oct 19, 2015 - Today, SyMyco, a joint venture between Symbiotic Sciences based in New Delhi, India and Mycorrhizal Applications (MA), based in Grants Pass, OR, announced it is expanding its U

Oct 16, 2015, 10:49 AM by Michael Croft

The New York Times | Dr. Heck shared the 2010 Nobel Prize in Chemistry for creating techniques to synthesize complex carbon molecules that are now used to make drugs, electronics and other products.

Oct 15, 2015, 10:45 AM by Michael Croft

Computerworld | Moving to the Cloud is changing more than just data location. It's changing everything about the skills IT workers need to do their jobs and what those jobs entail.

Oct 14, 2015, 16:45 PM by Michael Croft

Forbes | With a drug discovery business, an FDA-cleared test, and a new valuation at over $1 billions, 23andMe is once again on the upswing, writes Matthew Herper.

Oct 14, 2015, 13:30 PM by Michael Croft

Bio-IT World | The annual meeting of the ASHG convened last week in Baltimore, in the midst of a new Precision Medicine Initiative that aims to collect one million patients' genomes and medical records into a national cohort. As NIH Director Francis Collins spoke about the possibilities and social responsibilities of that project, ASHG President Neil Risch reflected on past and ongoing misuses of genetics, and a panel of science journalists considered how scientists can best engage the public, build trust, and help non-professionals wrangle with the real-world implications of new discoveries.